President Nana Addo Dankwa Akufo-Addo has reiterated his determination for a vaccine to be manufacture in Ghana In his 24th COVID-19 address on Sunday, 28 February 2021, the President said: “I want to reiterate my determination that we should manufacture vaccines here in Ghana”. “To this end, a Committee has been established under the Chairmanship of the former Minister for Environment, Science, Technology and Innovation, the world-renowned scientist, Professor Kwabena Frimpong-Boateng, which is formulating a concrete plan of action towards vaccine development and manufacturing”. President further pointed, that the Food and Drugs Authority (FDA) is also in the process of certifying more vaccines for use. Read the President’s full statement below: Address To The Nation By The President Of The Republic, Nana Addo Dankwa Akufo-Addo, On Updates To Ghana’s Enhanced Response To The Coronavirus Pandemic, On Sunday, 28th February 2021. Fellow Ghanaians, Good evening, and thank you for welcoming me into your homes once again. You are doing so on one of the sacred days of our nation, 28th February, when the 1948 Christiansborg Crossroads shooting occurred seventy-three (73) years ago, which led to the martyrdoms of Sergeant Adjetey, Corporal Attipoe, and Private Odartey Lamptey, martyrdoms that ignited the nationalist movement, and led us to the freedom we enjoy today. Let us observe a moment’s silence in honour of their memory, and the memory of all the faithful departed patriots who helped create our nation. May their souls rest in perfect peace. Fellow Ghanaians, since I last spoke to you, a month ago, a significant development in our fight against COVID-19 has taken place in our country. In the course of this week, Wednesday, 24th February, to be precise, we took another concrete step in our quest to rid our nation of COVID-19, with the arrival in the country of six hundred thousand (600,000) doses of the AstraZeneca vaccine, the first consignment of many more to come. I indicated in Update No. 23 that the earliest vaccine would be in the country by March. However, by dint of hard work and sheer determination, the government was able to secure the first batch of vaccine doses in February, a month ahead of schedule. We are the first country in the world to be recipients of vaccines from the COVAX Facility, and I want to express my appreciation to members of the COVID-19 Taskforce, which I chair, and to officials of the Ministry of Health and the Ghana Health Service for this commendable feat. The vaccine deployment plan we submitted to WHO, which unlocked this consignment, was well-received. They have done a yeoman’s job, and our nation is indebted to them. We are grateful, also, naturally, to the contributors and managers of the COVAX Facility. The AstraZeneca vaccine is one of two (2) vaccines that have, so far, been approved and declared as safe-for-use by the Food and Drugs Authority (FDA). With the process of certification currently ongoing for the other vaccines, the range of vaccines available to us will increase. This will facilitate our ability to reach our target of vaccinating twenty million Ghanaians by the end of this year. Through the National Vaccine Deployment Plan, our population has been segmented into four groups, and this will determine which section of the population gets vaccinated at a particular time. Group 1 is categorised as “persons most at risk and frontline State officials”. It includes healthcare workers, frontline security personnel, persons with underlying medical conditions, persons sixty (60) years and above, and frontline members of the Executive, Legislature and Judiciary. Group 2 is made up of other essential service providers and the rest of the security agencies. It includes water and electricity supply services, teachers and students, supply and distribution of fuels, farmers and food value chain, telecommunications services, air traffic and civil aviation control services, meteorological services, air transport services, waste management services, media, public and private commercial transport services, the Police Service, Armed Forces, Prisons Service, Immigration Service, National Fire Service, CEPS Division of the Ghana Revenue Authority, and other members of the Executive, Judiciary, and Legislature. Group 3 consists of the rest of the general public that is all persons over eighteen (18) years, except for pregnant women. The final group, that is Group 4, will include pregnant mothers and persons under the age of eighteen (18), and they will be vaccinated when an appropriate vaccine, hopefully, is found, or when enough safety data on the present vaccines is available. Special arrangements will be made for persons with disabilities who fall within these groups. So, from Tuesday, 2nd March, to Monday, 15th March 2021, the Ghana Health Service will begin deployment of the six hundred thousand (600,000) AstraZeneca vaccines, with persons in Groups 1 and 2 being the target of this first vaccination campaign. It will be conducted in forty-three (43) districts, which are the epicentres of the pandemic in the country. They are twenty-five (25) in Greater Accra, sixteen (16) in Ashanti, and two (2) in the Central Region. The Ghana Health Service, as from tomorrow, will give precise details. Whilst we are, initially, concentrating on the forty-three (43) epicentre-districts, preparations are being made for the vaccination of twenty million Ghanaians through the deployment of some twelve thousand and seventy-one (12,471) vaccinators, thirty-seven thousand, four hundred and thirteen (37,413) volunteers, and two thousand, and seventy-nine (2,079) supervisors for the entire vaccination campaign. Fellow Ghanaians, I know there are still some who continue to express doubts about the vaccine, others have expressed reservations about its efficacy, with some taking sides with conspiracy theorists who believe the vaccine has been created to wipe out the African race. This is far from the truth. Our domestic regulatory agency, FDA, one of the most reputable in Africa and in the world, has certified the safe use of the vaccine. It will not do so if it had any reservations about the safety of the vaccine, and I have gone on record as saying that no vaccine will be deployed in the